<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONDENSED CONSOLIDATED STATEMENT OF EARNINGS FOR THE THREE MONTHS ENDED MARCH 31, 2000, AND THE CONDENSED CONSOLIDATED BALANCE SHEET AS OF MARCH 31, 2000, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <MULTIPLIER> 1,000 <CURRENCY> U.S.DOLLARS <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> DEC-31-2000 <PERIOD-START> JAN-01-2000 <PERIOD-END> MAR-31-2000 <EXCHANGE-RATE> 1 <CASH> 680,894 <SECURITIES> 94,453 <RECEIVABLES> 2,176,481 <ALLOWANCES> 235,001 <INVENTORY> 1,622,309 <CURRENT-ASSETS> 6,727,906 <PP&E> 9,891,241 <DEPRECIATION> 5,110,228 <TOTAL-ASSETS> 14,960,923 <CURRENT-LIABILITIES> 4,500,645 <BONDS> 1,326,746 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 2,001,434 <OTHER-SE> 5,872,133 <TOTAL-LIABILITY-AND-EQUITY> 14,960,923 <SALES> 3,353,178 <TOTAL-REVENUES> 3,353,178 <CGS> 1,496,447 <TOTAL-COSTS> 1,496,447 <OTHER-EXPENSES> 321,367<F1> <LOSS-PROVISION> (2,256) <INTEREST-EXPENSE> 32,215 <INCOME-PRETAX> 949,256 <INCOME-TAX> 256,299 <INCOME-CONTINUING> 692,957 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 692,957 <EPS-BASIC> 0.45 <EPS-DILUTED> 0.44 <FN> <F1>OTHER EXPENSES CONSIST OF RESEARCH AND DEVELOPMENT EXPENSE. </FN>